Cyclopharm Limited (ASX:CYC – Get Free Report) insider David Heaney acquired 10,000 shares of the firm’s stock in a transaction dated Tuesday, October 31st. The stock was bought at an average cost of A$2.04 ($1.30) per share, for a total transaction of A$20,400.00 ($12,993.63). Cyclopharm Stock Performance The company has a current ratio of 3.90, […]